Pulmonary Histoplasmosis: A Clinical Update
Journal of Fungi · 10.02.2023 · 9 (2) · 236
DOI: 10.3390/jof9020236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 10.02.2023. Verfasst von Nicolas Barros und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Histoplasma capsulatum, the etiological agent for histoplasmosis, is a dimorphic fungus that grows as a mold in the environment and as a yeast in human tissues. The areas of highest endemicity lie within the Mississippi and Ohio River Valleys of North America and parts of Central and South America. The most common clinical presentations include pulmonary histoplasmosis, which can resemble community-acquired pneumonia, tuberculosis, sarcoidosis, or malignancy; however, certain patients can develop mediastinal involvement or progression to disseminated disease. Understanding the epidemiology, pathology, clinical presentation, and diagnostic testing performance is pivotal for a successful diagnosis. While most immunocompetent patients with mild acute or subacute pulmonary histoplasmosis should receive therapy, all immunocompromised patients and those with chronic pulmonary disease or progressive disseminated disease should also receive therapy. Liposomal amphotericin B is the agent of choice for severe or disseminated disease, and itraconazole is recommended in milder cases or as “step-down” therapy after initial improvement with amphotericin B. In this review, we discuss the current epidemiology, pathology, diagnosis, clinical presentations, and management of pulmonary histoplasmosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Division of Infectious Diseases, Indiana University Health, Indianapolis, IN 46202, USA.
- MiraVista Diagnostics, 4705 Decatur Boulevard, Indianapolis, IN 46241, USA.
- Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Lung Transplant, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Zitieren
APA
Barros, N., Wheat, J. L., & Hage, C. (2023). Pulmonary Histoplasmosis: A Clinical Update. Journal of Fungi, 9(2), 236. https://doi.org/10.3390/jof9020236
Vancouver
Barros N, Wheat JL, Hage C. Pulmonary Histoplasmosis: A Clinical Update. Journal of Fungi. 2023;9(2):236. doi:10.3390/jof9020236
BibTeX
@article{Barros2023,
author = {Barros, Nicolas and Wheat, Joseph L and Hage, Chadi},
title = {Pulmonary Histoplasmosis: A Clinical Update},
journal = {Journal of Fungi},
year = {2023},
volume = {9},
number = {2},
pages = {236},
doi = {10.3390/jof9020236}
}
EUVIMED